You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

palbociclib

Showing 1 - 25 of 184
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Breast Cancer Trial in Al Madinah (Palbociclib)

Not yet recruiting
  • Metastatic Breast Cancer
  • Palbociclib
  • Al Madīnah, AL, Saudi Arabia
    Asmaa Imam Ahmed
Oct 8, 2023

Breast Cancer Trial in Orange City (ARV-471 (PF-07850327), Palbociclib, Letrozole)

Recruiting
  • Breast Cancer
  • ARV-471 (PF-07850327)
  • +2 more
  • Orange City, Florida
    Mid Florida Hematology and Oncology Center
Jun 8, 2023

Palbociclib in Canadian Breast Cancer That Has Spread to Other

Not yet recruiting
  • Breast Cancer
  • Palbociclib
  • (no location specified)
Aug 18, 2023

Undifferentiated Pleomorphic Sarcoma Trial in Iowa City (Palbociclib, Pembrolizumab)

Not yet recruiting
  • Undifferentiated Pleomorphic Sarcoma
  • Iowa City, Iowa
    University of Iowa Hospitals & Clinics
Nov 1, 2023

Compare Overall Survival in Medicare Metastatic Breast Cancer

Active, not recruiting
  • Breast Cancer
  • Palbociclib
  • Aromatase Inhibitor
  • New York, New York
    Pfizer New York
Oct 11, 2023

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

Not yet recruiting
  • ccRCC
  • +20 more
  • (no location specified)
Jul 6, 2023

DCIS Trial in Washington (Palbociclib)

Recruiting
  • DCIS
  • Palbociclib
  • Washington, District of Columbia
  • +1 more
Jan 23, 2023

Esophagus Squamous Cell Carcinoma Trial in Beijing (Palbociclib, Afatinib)

Recruiting
  • Esophagus Squamous Cell Carcinoma
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospital, Chinese Academy of Medic
May 17, 2023

Advanced Dedifferentiated Liposarcoma, Locally Advanced Dedifferentiated Liposarcoma, Metastatic Dedifferentiated Liposarcoma

Not yet recruiting
  • Advanced Dedifferentiated Liposarcoma
  • +5 more
  • Palbociclib
  • +5 more
  • (no location specified)
Jan 11, 2023

Breast Cancer Trial in Groningen (Palbociclib, FES PET, Letrozole)

Completed
  • Breast Cancer
  • Palbociclib
  • +2 more
  • Groningen, Netherlands
    University Medical Center Groningen
Oct 11, 2022

Head Neck Cancer, Locally Advanced Trial in Bangkok (Palbociclib, Cetuximab, Intensity Modulated Radiation Therapy)

Active, not recruiting
  • Head and Neck Cancer
  • Locally Advanced
  • Palbociclib
  • +2 more
  • Bangkok, Thailand
    Faculty of Medicine, Ramathibodi Hospital
Sep 19, 2022

Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Therapy Trial in Taipei City, Taipei (Palbociclib, Ribociclib,

Recruiting
  • Breast Cancer
  • +2 more
  • Palbociclib
  • +3 more
  • Taipei City, Taiwan
  • +1 more
Mar 15, 2023

COVID-19 Trial in Brandenburg an der Havel (Palbociclib)

Withdrawn
  • COVID-19
  • Palbociclib
  • Brandenburg an der Havel, Germany
    Universitätsklinikum Brandenburg an der Havel
Nov 3, 2022

Renal Cell Carcinoma, Ovarian Carcinoma, Thyroid Carcinoma Trial in Groningen (Olaparib, Lenvatinib, Sunitinib)

Not yet recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Groningen, Netherlands
    University Medical Center Groningen
Jul 13, 2023

Tumor, Solid, Pancreatic Cancer Trial in Chapel Hill (Ulixertinib, Palbociclib)

Recruiting
  • Tumor, Solid
  • +2 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Nov 30, 2022

Breast Cancer Stage IV, Unresectable Locally Advanced Invasive Breast Cancer, Metastatic Invasive Breast Cancer Trial in Boston

Completed
Has Results
  • Breast Cancer Stage IV
  • +2 more
  • Boston, Massachusetts
  • +1 more
Oct 21, 2022

Real-World Evidence In Patients Treated With Palbociclib

Recruiting
  • Metastatic Breast Cancer
  • Palbociclib
  • Timisoara, Timiș, Romania
  • +5 more
Dec 7, 2022

Breast Cancer, Head Neck Cancer Trial in Seoul (Palbociclib, Cetuximab, Fulvestrant)

Recruiting
  • Breast Cancer
  • Head and Neck Cancer
  • Palbociclib
  • +3 more
  • Seoul, Seoul-teukbyeolsi [seoul], Korea, Republic of
  • +3 more
Dec 14, 2022

Metastatic Breast Cancer (MBC) Trial in United States (Palbociclib, Bicalutamide)

Active, not recruiting
  • Metastatic Breast Cancer (MBC)
  • Basking Ridge, New Jersey
  • +4 more
Oct 31, 2022

Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Los Angeles (procedure, drug, other)

Terminated
  • Estrogen Receptor Positive
  • +16 more
  • Biopsy of Breast
  • +5 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Sep 22, 2022

Malignant Female Reproductive System Tumor, Malignant Solid Tumor, Recurrent Malignant Female Reproductive System Tumor Trial

Not yet recruiting
  • Malignant Female Reproductive System Neoplasm
  • +3 more
  • Biopsy
  • +7 more
  • (no location specified)
Nov 9, 2023

Renal Cell Carcinoma Trial in Macquarie University, Haifa (Belzutifan, Palbociclib)

Recruiting
  • Renal Cell Carcinoma
  • Macquarie University, New South Wales, Australia
  • +1 more
Aug 15, 2022

Advanced Clear Cell Renal Cell Carcinoma Trial in Boston (Axitinib, Palbociclib, Avelumab)

Not yet recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • Boston, Massachusetts
  • +2 more
Jun 27, 2022

Breast Cancer Trial in Canton (TTI-101, Palbociclib, Aromatase inhibitor (AI))

Recruiting
  • Breast Cancer
  • Saint Louis, Missouri
  • +2 more
Jan 12, 2023

Breast Cancer Trial in Worldwide (Ipatasertib, Placebo, Palbociclib)

Active, not recruiting
  • Breast Cancer
  • Atlanta, Georgia
  • +19 more
Dec 5, 2022